Prevalence and molecular characterization of pertactin-deficient Bordetella pertussis in the United States. - Wikidata - awgldk - TriplyDB

Prevalence and molecular characterization of pertactin-deficient Bordetella pertussis in the United States.

Prevalence and molecular characterization of pertactin-deficient Bordetella pertussis in the United States.

http://www.wikidata.org/entity/Q37545038

about

Roads to the development of improved pertussis vaccines paved by immunology Old Disease and New Challenges: Major Obstacles of Current Strategies in the Prevention of Pertussis.Bordetella pertussis evolution in the (functional) genomics era Novel therapies for the treatment of pertussis disease Acquisition and loss of virulence-associated factors during genome evolution and speciation in three clades of Bordetella species Proteomics-identified Bvg-activated autotransporters protect against bordetella pertussis in a mouse model.Highlights of the 11th International Bordetella Symposium: from Basic Biology to Vaccine Development.Complete Genome Sequence of Bordetella pertussis Strain VA-190 Isolated from a Vaccinated 10-Year-Old Patient with Whooping Cough Complete Genome Sequences of 11 Bordetella pertussis Strains Representing the Pandemic ptxP3 Lineage.Severe pertussis infection in infants less than 6 months of age: Clinical manifestations and molecular characterization.Geospatial analysis of nonmedical vaccine exemptions and pertussis outbreaks in the United States.The vaccine potential of Bordetella pertussis biofilm-derived membrane proteins.Molecular epidemiology of the pertussis epidemic in Washington State in 2012.Bordetella pertussis pathogenesis: current and future challenges.Immune responses to pertussis antigens in infants and toddlers after immunization with multicomponent acellular pertussis vaccine.Bordetella pertussis naturally occurring isolates with altered lipooligosaccharide structure fail to fully mature human dendritic cells Analysis of Bordetella pertussis clinical isolates circulating in European countries during the period 1998-2012.Pertussis outbreak, southeastern Minnesota, 2012.Emerging, evolving, and established infectious diseases and interventions A Proteomic Characterization of Bordetella pertussis Clinical Isolates Associated with a California State Pertussis Outbreak.Tracking Pertussis and Evaluating Control Measures through Enhanced Pertussis Surveillance, Emerging Infections Program, United States.Effect of Culture-Independent Diagnostic Tests on Future Emerging Infections Program Surveillance.Contribution of pertussis toxin to the pathogenesis of pertussis disease Strategies and new developments to control pertussis, an actual health problem Development of a qualitative assay for screening of Bordetella pertussis isolates for pertussis toxin production.Bordetella pertussis Isolates from Argentinean Whooping Cough Patients Display Enhanced Biofilm Formation Capacity Compared to Tohama I Reference Strain.Sustained Transmission of Pertussis in Vaccinated, 1-5-Year-Old Children in a Preschool, Florida, USA.Bordetella pertussis Strain Lacking Pertactin and Pertussis Toxin Changes in Predominance of Pulsed-Field Gel Electrophoresis Profiles of Bordetella pertussis Isolates, United States, 2000-2012 Bordetella pertussis: new concepts in pathogenesis and treatment Comparison of molecular detection methods for pertussis in children during a state-wide outbreak.Development of improved pertussis vaccine.Increase in pertussis cases along with high prevalence of two emerging genotypes of Bordetella pertussis in Perú, 2012 Emerging Bordetella pertussis Strains Induce Enhanced Signaling of Human Pattern Recognition Receptors TLR2, NOD2 and Secretion of IL-10 by Dendritic Cells.Rapid increase in pertactin-deficient Bordetella pertussis isolates, Australia.Significant Decrease in Pertactin-Deficient Bordetella pertussis Isolates, Japan.Healthcare workers as vectors of infectious diseases.Bordetella pertussis and pertactin-deficient clinical isolates: lessons for pertussis vaccines.Adult pertussis in the pre- and post-vaccine eras: lifelong vaccine-induced immunity?Importance of (antibody-dependent) complement-mediated serum killing in protection against Bordetella pertussis.

P2860

Q26782939-1E226310-C670-473D-87E1-DEC7A9582C29 Q27691413-256B1453-3BB7-4E27-9762-F271D4F7E2C4 Q28082989-392478A2-4C30-448D-8314-DF707F3C64B2 Q28084039-57519DE5-0C68-49F5-9DE0-24C8ACA9FF0F Q28828144-4F1B6DE3-D20D-462E-BA63-F29D85FF7B80 Q30208978-956EDAB5-49C7-4F9D-8791-A0CA860E9791 Q30245164-4502D0A6-E9A0-4C36-A125-39D29E9CCB61 Q30275932-F8C3B465-321C-47CA-8854-655C2038FE63 Q30381881-FA1257A1-A3B5-4F38-88D7-16C1DD374EB0 Q33724387-E88359A3-87E1-4456-8E9B-B01AA13F0B97 Q33886984-4E332367-09D7-4D74-A1AB-F93B3733C884 Q34113606-C359CDC0-2F42-4CBA-81BB-B8669C2A56AF Q34298066-7D3A29B1-2540-4E28-BCEC-7BC168EA9F90 Q34383541-D4DA69A6-9423-4BBC-9DE8-3E0D29FADEFE Q34593062-AAACF08A-A118-4F92-965A-9DA3E38689ED Q34889754-1BBE7BC7-F5D7-497E-8B50-3AF8DCA3E0D0 Q35193398-4FCDB905-F1FD-4B7D-8DC0-F4CF08AB6D38 Q35456030-02E9246F-ECA3-436B-8F9B-C6D21797164D Q35534867-095E286E-7BF1-43EB-9BAD-1CDDD06C5196 Q35690712-2BF0FA83-9AE2-45AF-A452-E3255A6EB23F Q35997485-8139DE82-DB3B-4FCB-836E-18157DFF307B Q35997535-1137135F-B77B-4DB4-B748-B541FE61A5F0 Q36226458-3985F48C-EDE2-4E79-B0AC-A1E1F3ECDCA1 Q36226470-EE42A418-5FF0-43D5-9D61-7E7EA0AD088C Q36342210-0F86B22E-F834-44A6-A36A-8F4A3544372D Q36354539-1C29F955-2AE2-4400-9DC4-0720A423FDEE Q36525266-73F92478-BC83-49EE-9BB5-7E9CFB79166A Q36525295-B487FB69-3DE0-48F2-A918-3284CBF38B7B Q36617112-1A871F4C-8C0B-4667-AE20-B4B9756FAA07 Q36839952-FBA94BE2-A963-43C2-9932-7DF951472EB4 Q36842297-B503FE7A-6E0E-4517-A800-89CAA5D3EEC4 Q36978320-EC199D77-2166-4816-9ECB-6A6E3AE519B1 Q37182380-FC55E825-18F5-43A4-8C97-C44BB25FC45E Q37580659-76022DB3-EE92-4FA1-BD7E-74138E2B2362 Q37664578-56579D42-DD06-4B1B-9287-D31E9DF5A719 Q37722269-4288E767-6C37-4827-8770-477325896A92 Q38209531-929FC4B6-B316-41F5-A199-C170F54EF9BA Q38222258-9B2CA503-A621-438B-9A1A-EDD7677A987C Q38225351-13C6B0D9-BFFB-4660-8D4B-20B1D69C60E4 Q38235833-77A72551-9DF9-4C70-854D-2D41A88A739B

P2860

Prevalence and molecular characterization of pertactin-deficient Bordetella pertussis in the United States.

http://www.wikidata.org/entity/Q37545038

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

2013年學術文章

@zh

2013年學術文章

@zh-hant

name

Prevalence and molecular chara ...... ertussis in the United States.

@en

Prevalence and molecular chara ...... ertussis in the United States.

@nl

type

label

Prevalence and molecular chara ...... ertussis in the United States.

@en

Prevalence and molecular chara ...... ertussis in the United States.

@nl

prefLabel

Prevalence and molecular chara ...... ertussis in the United States.

@en

Prevalence and molecular chara ...... ertussis in the United States.

@nl

P1433

Q37545038-04A3FEA8-E678-4C68-B4AD-61298C7B6202

P1476

Q37545038-CB10A336-C0C3-4324-9726-75B25351001E

P2093

Q37545038-04D0FC80-F4F9-49FE-95B8-D84B96E63D17

Q37545038-20CAFDB5-EA9F-4C96-81D2-39510B13E11C

Q37545038-5B974612-017A-41CF-A325-7D6347FAA379

Q37545038-65FA077D-F457-4C05-9F8E-7E6B4125CF96

Q37545038-7EF4DD7C-1AE9-4B59-80F2-94CA351F2747

Q37545038-84950A67-9296-4C6E-89D5-7E9C3D9A8DF5

Q37545038-880A1EBA-AF35-4345-8B79-9D63844A332A

Q37545038-97444F6A-BF81-4564-B253-0A49559DDE6D

Q37545038-C8E21216-1957-4AD0-80C0-58A0C222C9E8

Q37545038-E19135AE-34C5-424E-BDB7-0531C7BC1DB2

P2860

Q37545038-16AC6DF4-3EE2-4FBF-B030-3D5AC25500B3

Q37545038-37EADC56-41CF-4D35-BE19-F3EA4B29E02B

Q37545038-3E911B50-19FC-4E1A-8ABE-E8E7AA52427D

Q37545038-400A31E4-DD92-4346-B1F0-12032EE86865

Q37545038-47F54778-8CF0-4EF9-BA91-78A475C29AE0

Q37545038-4B7AF4C4-EF64-47C2-92B7-018F2098D3A2

Q37545038-5CFA960D-B28A-4D51-9AAC-9D0D3F7C9E2F

Q37545038-64696904-08B3-4BD0-8EBF-717C64C6E481

Q37545038-67880A2E-C169-4764-B7F0-CED2E6ACD735

Q37545038-68981FDE-4717-4ED4-B802-3618EFB95F19

P304

Q37545038-A141D599-FC3A-4A47-800B-298FC95BB66E

P31

Q37545038-592744F2-B06F-4A93-B83D-D092AB222DF1

P356

Q37545038-C88B3C75-06FC-449D-B037-F00FCDE0E8C2

P433

Q37545038-1194D8B6-43B3-43C6-AD23-EF55C8A72245

P478

Q37545038-39A0A5D1-75F9-45A4-9BB0-E3E47092CA4F

P50

Q37545038-4DDA0483-D346-40C1-B449-D1D61E2B4782

P577

Q37545038-F23ED06F-1A7C-452D-9142-E0E6B86B9F13

P698

Q37545038-C2B39EEF-BA9B-412B-8848-66B15BAE3CE4

P921

Q37545038-616DC98A-E30C-4C14-8F50-DDE1C408D195

P932

Q37545038-A025BC25-E879-497C-9609-421C6AEDEB55

P356

P1433

Clinical and Vaccine Immunology

P1476

Prevalence and molecular chara ...... pertussis in the United States

@en

P2093

A M Queenan

http://www.w3.org/2001/XMLSchema#string

A S Lynch

http://www.w3.org/2001/XMLSchema#string

B Burgos-Rivera

http://www.w3.org/2001/XMLSchema#string

L C Pawloski

http://www.w3.org/2001/XMLSchema#string

M J Harrison

http://www.w3.org/2001/XMLSchema#string

M L Tondella

http://www.w3.org/2001/XMLSchema#string

M M Williams

http://www.w3.org/2001/XMLSchema#string

N Messonnier

http://www.w3.org/2001/XMLSchema#string

P K Cassiday

http://www.w3.org/2001/XMLSchema#string

W Shang

http://www.w3.org/2001/XMLSchema#string

P2860

Changes in predominance and diversity of genomic subtypes of Bordetella pertussis isolated in the United States, 1935 to 1999

Nucleotide sequence and characterization of a repetitive DNA element from the genome of Bordetella pertussis with characteristics of an insertion sequence.

Genomic content of Bordetella pertussis clinical isolates circulating in areas of intensive children vaccination.

Type V protein secretion pathway: the autotransporter story

Polymorphism in the Bordetella pertussis virulence factors P.69/pertactin and pertussis toxin in The Netherlands: temporal trends and evidence for vaccine-driven evolution

Seroprevalence of pertussis in The Netherlands: evidence for increased circulation of Bordetella pertussis.

Prevalence and genetic characterization of pertactin-deficient Bordetella pertussis in Japan.

Rationale for pertussis booster vaccination throughout life in Europe.

Resurgence of pertussis calls for re-evaluation of pertussis animal models.

Small mutations in Bordetella pertussis are associated with selective sweeps.

P304

119-125

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/CVI.00717-13

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

21

http://www.w3.org/2001/XMLSchema#string

P50

Katherine E Bowden

P577

2013-11-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24256623

http://www.w3.org/2001/XMLSchema#string

P921

Bordetella pertussis

P932

3910938

http://www.w3.org/2001/XMLSchema#string